financetom
Business
financetom
/
Business
/
Utz Brands Shares Rise After Higher Q2 Adjusted Earnings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Utz Brands Shares Rise After Higher Q2 Adjusted Earnings
Aug 1, 2024 8:13 AM

10:54 AM EDT, 08/01/2024 (MT Newswires) -- Utz Brands ( UTZ ) shares were up nearly 5% in recent Thursday trading after the company posted higher Q2 adjusted earnings and raised its 2024 EPS outlook.

The company reported Q2 adjusted earnings of $0.19 per share, up from $0.13 a year earlier.

Analysts polled by Capital IQ expected $0.16.

Net sales for the quarter that ended June 30 were $356.2 million, down from $362.9 million a year earlier.

Analysts polled by Capital IQ expected $356.2 million.

The company raised its full-year adjusted EPS growth outlook to between 28% and 32% from the previous range of 23% to 28%. Analysts polled by Capital IQ expect $0.71.

Price: 15.54, Change: +0.70, Percent Change: +4.72

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Car equipment supplier Autoliv beats operating profit estimates in third quarter
Car equipment supplier Autoliv beats operating profit estimates in third quarter
Oct 17, 2025
(Reuters) -Autoliv ( ALV ), the world's largest producer of airbags and seatbelts, reported a third-quarter adjusted operating profit above market expectations on Friday and said it had recovered around 75% of the tariff-related costs in the quarter. Adjusted operating profit grew to $271 million in the quarter, from $237 million a year earlier, beating analysts' mean forecast of $248...
XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
Oct 17, 2025
CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ( XRTX ) (“XORTX” or the “Company”) , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that it has entered into a binding term sheet (the “Term Sheet”) to acquire a Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems...
Form 8.3 - Unite Group
Form 8.3 - Unite Group
Oct 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: CCLA Investment Management Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
Oct 17, 2025
Acquisition to expand the neuromodulation offerings for people living with chronic pain MARLBOROUGH, Mass., Oct. 17, 2025 /PRNewswire/ -- Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic pain. Boston Scientific (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved